190 related articles for article (PubMed ID: 32209370)
1. A new nanovesicular system for nasal drug administration.
Touitou E; Duchi S; Natsheh H
Int J Pharm; 2020 Apr; 580():119243. PubMed ID: 32209370
[TBL] [Abstract][Full Text] [Related]
2. Phospholipid Magnesome-a nasal vesicular carrier for delivery of drugs to brain.
Natsheh H; Touitou E
Drug Deliv Transl Res; 2018 Jun; 8(3):806-819. PubMed ID: 29524165
[TBL] [Abstract][Full Text] [Related]
3. Bioavailability of tramadol hydrochloride after administration via different routes in rats.
Zhang H; Zhao Y; Wang X; Zhang Q
Biopharm Drug Dispos; 2014 Dec; 35(9):525-31. PubMed ID: 25170803
[TBL] [Abstract][Full Text] [Related]
4. Enhanced analgesic responses after preferential delivery of morphine and fentanyl to the olfactory epithelium in rats.
Hoekman JD; Ho RJ
Anesth Analg; 2011 Sep; 113(3):641-51. PubMed ID: 21709146
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of tramadol in rat plasma and cerebrospinal fluid after intranasal administration.
Zhao Y; Tao T; Wu J; Pi J; He N; Chai X; Chen Q
J Pharm Pharmacol; 2008 Sep; 60(9):1149-54. PubMed ID: 18718117
[TBL] [Abstract][Full Text] [Related]
6. Short Onset and Enhanced Analgesia Following Nasal Administration of Non-Controlled Drugs in Nanovesicular Systems.
Touitou E; Natsheh H; Boukeileh S; Awad R
Pharmaceutics; 2021 Jun; 13(7):. PubMed ID: 34203555
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery.
Alex AT; Joseph A; Shavi G; Rao JV; Udupa N
Drug Deliv; 2016 Sep; 23(7):2144-2153. PubMed ID: 25544603
[TBL] [Abstract][Full Text] [Related]
8. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
[TBL] [Abstract][Full Text] [Related]
9. Design and development of nasal mucoadhesive microspheres containing tramadol HCl for CNS targeting.
Belgamwar VS; Patel HS; Joshi AS; Agrawal A; Surana SJ; Tekade AR
Drug Deliv; 2011 Jul; 18(5):353-60. PubMed ID: 21351825
[TBL] [Abstract][Full Text] [Related]
10. Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo evaluation.
Galgatte UC; Kumbhar AB; Chaudhari PD
Drug Deliv; 2014 Feb; 21(1):62-73. PubMed ID: 24191774
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of brain targeting and mucosal integrity of nasally administrated nanostructured carriers of a CNS active drug, clonazepam.
Abdel-Bar HM; Abdel-Reheem AY; Awad GA; Mortada ND
J Pharm Pharm Sci; 2013; 16(3):456-69. PubMed ID: 24021293
[TBL] [Abstract][Full Text] [Related]
12. Strategies to facilitate or block nose-to-brain drug delivery.
Martins PP; Smyth HDC; Cui Z
Int J Pharm; 2019 Oct; 570():118635. PubMed ID: 31445062
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the Absorption of Nanosized lamotrigine Containing Nasal Powder via the Nasal Cavity.
Ambrus R; Gieszinger P; Gáspár R; Sztojkov-Ivanov A; Ducza E; Márki Á; Janáky T; Tömösi F; Kecskeméti G; Szabó-Révész P; Bartos C
Molecules; 2020 Feb; 25(5):. PubMed ID: 32120992
[TBL] [Abstract][Full Text] [Related]
14. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
[TBL] [Abstract][Full Text] [Related]
15. Buspirone Hydrochloride Loaded In Situ Nanovesicular Gel as an Anxiolytic Nasal Drug Delivery System: In Vitro and Animal Studies.
Abdelnabi DM; Abdallah MH; Elghamry HA
AAPS PharmSciTech; 2019 Mar; 20(3):134. PubMed ID: 30830481
[TBL] [Abstract][Full Text] [Related]
16. Buspirone Nanovesicular Nasal System for Non-Hormonal Hot Flushes Treatment.
Touitou E; Natsheh H; Duchi S
Pharmaceutics; 2018 Jul; 10(3):. PubMed ID: 29970859
[TBL] [Abstract][Full Text] [Related]
17. Development, Optimization, and Evaluation of Carvedilol-Loaded Solid Lipid Nanoparticles for Intranasal Drug Delivery.
Aboud HM; El Komy MH; Ali AA; El Menshawe SF; Abd Elbary A
AAPS PharmSciTech; 2016 Dec; 17(6):1353-1365. PubMed ID: 26743643
[TBL] [Abstract][Full Text] [Related]
18. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
[TBL] [Abstract][Full Text] [Related]
19. Nanosized Drug Delivery Systems for Direct Nose to Brain Targeting: A Review.
Phukan K; Nandy M; Sharma RB; Sharma HK
Recent Pat Drug Deliv Formul; 2016; 10(2):156-64. PubMed ID: 26996366
[TBL] [Abstract][Full Text] [Related]
20. Development of novel bioadhesive granisetron hydrochloride spanlastic gel and insert for brain targeting and study their effects on rats.
Abdelmonem R; El Nabarawi M; Attia A
Drug Deliv; 2018 Nov; 25(1):70-77. PubMed ID: 29228824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
